aTyr Pharma: Interesting Drug, Difficult Target Market
Tyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors ...
Hosted on MSN2d
Cantor Fitzgerald Initiates Coverage of aTyr Pharma (ATYR) with Overweight Recommendation
Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...
This Toast Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including ...
Atyr PHARMA (NASDAQ:ATYR) Now Covered by Cantor Fitzgerald
Equities research analysts at Cantor Fitzgerald started coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research report issued to clients and investors on Monday,Briefing.com ...
aTyr Pharma initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of aTyr Pharma (ATYR) with an Overweight rating. aTyr Pharma’s lead drug Efzofitimod is in two trials for ...
Pharmaceutical Technology9d
Efzofitimod by ATyr Pharma for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Efzofitimod is under clinical development by aTyr Pharma and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.
parktelegraph16d
Taking On Challenges And Growing? – Atyr Pharma Inc (ATYR)
The current market capitalization of Atyr Pharma Inc is $301.74M. A total of 0.75 million shares were traded on the day, compared to an average of 989.25K shares. In the most recent transaction, ...
Bloomberg L.P.16d
Swiss PE Eyes IT, Pharma in India Portfolio Rejig after 300% Gain
Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Swiss private equity firm Partners Group Holding AG is ...